ask="3.40"
ask_size="9700"
average_daily_volume="57595"
bid="2.91"
bid_size="100"
book_value="1.19"
change="-0.10"
change_from_200_day_moving_average="-1.20"
change_from_50_day_moving_average="-0.53"
change_from_52_week_high="-3.47"
change_From_52_week_low="0.08"
change_in_percent="-3.23%"
close="3.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.90"
ebitda="-15.74M"
eps_estimate_current_year="-3.71"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.81"
ex_dividend_date="N/A"
float_shares="5652000"
high="3.16"
high_52_weeks="6.47"
last_trade_date="1/20/2017"
last_trade_price="3.00"
last_trade_size="200"
last_trade_time="4:00pm"
low="3.00"
low_52_weeks="2.92"
market_capitalization="18.89M"
moving_average_200_day="4.20"
moving_average_50_day="3.53"
name="MabVax Therapeutics Holdings
I"
notes="N/A"
one_year_target_price="18.00"
open="3.14"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-28.59%"
percent_change_from_50_day_moving_average="-15.05%"
percent_change_from_52_week_high="-53.67%"
percent_change_from_52_week_low="+2.74%"
previous_close="3.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.60"
price_per_sales="21.55"
revenue="905615.00"
shares_outstanding="6296000"
short_ratio="5.29"
stock_exchange="NCM"
symbol="MBVX"
volume="42779"
weeks_range_52="2.92 - 6.47"
